Dr. Michela Gallagher has been named the recipient of the 2018 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. The prize, awarded by the Alzheimer’s Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer’s disease and related dementias.
Dr. Gallagher, whose lifetime of research in cognitive neuroscience has focused on age-related cognitive decline, is the Krieger-Eisenhower Professor of Psychology and Neuroscience and heads the Neurogenetics and Behavior Center at Johns Hopkins University. She is also founder of AgeneBio, Inc. a pharmaceutical development company that has initiated a Phase 3 trial to delay the progression of Alzheimer’s dementia and a second track of research on a late-stage discovery program of therapies for Alzheimer’s, autism and schizophrenia.
The prize includes a $150,000…
